Knowledge (XXG)

Mario Moisés Álvarez

Source 📝

148:Álvarez's personal research specialties include design of bio-reactors, transport phenomena (particularly mixing), micro and nanotechnologies for biological applications, mathematical modeling of biological systems, tissue engineering, bioprinting, and point-of-care diagnostic. Álvarez has published more than 110 articles in prestigious international journals in his field (ei., Nature Reviews Materials, Advanced Materials, ACS Nano, PNAS, Scientific Reports, Biomaterials, 125:, which he founded. The center mainly develops food and pharmaceutical products (and processes) using a wide tool box that includes genetic engineering strategies, bioprocess engineering, biomedical engineering, and more classical biochemistry concepts. The Centro de Biotecnología-FEMSA is today one of the most productive research organizations of the Tec de Monterrey system. 78:
is a Mexican researcher. He was a visiting professor at the Harvard-MIT Division of Health Sciences and Technologies, at the Brigham Women's Hospital of the Harvard Medical School, in Cambridge Massachusetts (2014-2017). He also collaborated as a visiting professor in the Microsystems Technology
145:) is today one of the most productive Tissue Engineering Laboratories in Latin America and hosts the activity of postdoctoral researchers, graduate students, and undergraduate volunteers that are trained in state of the art techniques while publishing in high-impact international journals. 140:
In 2017, after a sabbatical period at Boston in the Khademhosseini Lab, Álvarez and Grissel Trujillo de Santiago established a new Laboratory at Tecnológico de Monterrey, with focus in Biomedical Engineering research, and with strong emphasis in Tissue Engineering and Bioprinting. The
128:
In 2007, Álvarez initiated the Biopharmaceutical Research Group at Tecnológico de Monterrey, a unit that became one of the most important research groups in this area in Latin America. Its activities have included the creation of a way to mass-produce a vaccine against the
87:, a permanent membership in the AMC (Mexican Academy of Sciences), two granted US patents and twelve granted Mexican patents. He received the Rómulo Garza Insignia Award in 2017, the most prestigious research award from his institution, Tecnológico de Monterrey. 298: 79:
Laboratories at MIT (2015-2016). Álvarez conducted research at the BIRC (Biomaterials Innovation Research Center) in the areas of Tissue Engineering, Biomaterials, and Microfluidics. Today, Mario Moisés Álvarez is a full professor at the
313: 166: 158:Álvarez has an H index of 37 (according to Scopus) and 40 (according to Scholar Google). He has been cited more than 6,000 times in scientific publications including Nature, PNAS, and Physical Review Letters. 103: 155:Álvarez's research work has been recognized by the Mexican government with Level III membership in the Sistema Nacional de Investigadores, the highest rank for a Mexican investigator. 59: 260: 80: 137:. Later, Álvarez's group became involved in the design and fabrication of Chips capable to produce monoclonal antibodies through anchorage dependent mammalian cell culture. 152:, among others), along with presenting in over one hundred international forums and conferences. He has directed more than 40 theses at the doctorate and masters level. 90:Álvarez's mother is a primary school teacher who insisted that her son attended the Tecnológico de Monterrey starting with high school, which he did at the 83:(Tecnológico de Monterrey), specializing in biomedical and biopharmaceutical engineering. His work has been recognized by Level III membership in Mexico's 318: 188: 267: 134: 84: 303: 117:
Since then, Álvarez has primarily been a researcher, former director (2004-2010) of the Centro de Biotecnología
149: 95: 308: 106:. He continued his education studying a masters and doctorate in chemical and biochemical engineering at 111: 107: 91: 44: 238: 292: 215: 17: 121:(FEMSA Center for Biotechnology), a biotechnology research facility in the city of 110:
in the research group of Professor Fernando Muzzio, and post-doctoral work at
299:
Academic staff of the Monterrey Institute of Technology and Higher Education
122: 189:"Mario Moisés Álvarez: un alumno becado que hoy diseña y crea biofármacos" 99: 167:
List of Monterrey Institute of Technology and Higher Education faculty
48: 142: 130: 118: 314:
Monterrey Institute of Technology and Higher Education alumni
114:
in the United States under the supervision of Dr. San Kiang.
239:"El ITESM desarrolla vacuna contra la influenza A/H1N1" 60:
Monterrey Institute of Technology and Higher Education
94:
campus. This was followed by undergraduate study in
81:
Monterrey Institute of Technology and Higher Studies
65: 55: 39: 32: 102:campus and a masters in the same field at the 8: 210: 208: 206: 29: 261:"Investigadores vigentes a enero de 2013" 183: 181: 177: 237:David Carrizales (October 20, 2009). 7: 85:Sistema Nacional de Investigadores 25: 266:. Mexico: CONACYT. Archived from 191:. Tec de Monterrey. May 22, 2013 319:21st-century Mexican scientists 143:https://alvareztrujillolab.com/ 27:Mexican researcher, born in Cd 1: 141:Álvarez-Trujillo Laboratory ( 335: 241:. La Jornada. p. 3 96:biochemical engineering 216:"Mario Moisés Álvarez" 273:on September 21, 2013 112:Bristol Myers Squibb 76:Mario Moisés Álvarez 34:Mario Moisés Álvarez 18:Mario Moises Alvarez 304:Mexican biochemists 218:. Tec de Monterrey 108:Rutgers University 133:virus during the 73: 72: 16:(Redirected from 326: 283: 282: 280: 278: 272: 265: 257: 251: 250: 248: 246: 234: 228: 227: 225: 223: 212: 201: 200: 198: 196: 185: 104:Monterrey campus 30: 21: 334: 333: 329: 328: 327: 325: 324: 323: 289: 288: 287: 286: 276: 274: 270: 263: 259: 258: 254: 244: 242: 236: 235: 231: 221: 219: 214: 213: 204: 194: 192: 187: 186: 179: 174: 164: 56:Alma mater 51: 35: 28: 23: 22: 15: 12: 11: 5: 332: 330: 322: 321: 316: 311: 306: 301: 291: 290: 285: 284: 252: 229: 202: 176: 175: 173: 170: 163: 160: 150:Biofabrication 71: 70: 67: 63: 62: 57: 53: 52: 43: 41: 37: 36: 33: 26: 24: 14: 13: 10: 9: 6: 4: 3: 2: 331: 320: 317: 315: 312: 310: 309:Living people 307: 305: 302: 300: 297: 296: 294: 269: 262: 256: 253: 240: 233: 230: 217: 211: 209: 207: 203: 190: 184: 182: 178: 171: 169: 168: 161: 159: 156: 153: 151: 146: 144: 138: 136: 135:2009 outbreak 132: 126: 124: 120: 115: 113: 109: 105: 101: 97: 93: 92:Ciudad Juárez 88: 86: 82: 77: 68: 64: 61: 58: 54: 50: 46: 45:Ciudad Juárez 42: 38: 31: 19: 275:. Retrieved 268:the original 255: 243:. Retrieved 232: 220:. Retrieved 193:. Retrieved 165: 157: 154: 147: 139: 127: 116: 89: 75: 74: 293:Categories 245:August 10, 222:August 10, 195:August 10, 172:References 69:Researcher 66:Occupation 277:August 7, 123:Monterrey 162:See also 100:Guaymas 98:at the 49:Mexico 271:(PDF) 264:(PDF) 131:AH1N1 119:FEMSA 279:2013 247:2013 224:2013 197:2013 40:Born 295:: 205:^ 180:^ 47:, 281:. 249:. 226:. 199:. 20:)

Index

Mario Moises Alvarez
Ciudad Juárez
Mexico
Monterrey Institute of Technology and Higher Education
Monterrey Institute of Technology and Higher Studies
Sistema Nacional de Investigadores
Ciudad Juárez
biochemical engineering
Guaymas
Monterrey campus
Rutgers University
Bristol Myers Squibb
FEMSA
Monterrey
AH1N1
2009 outbreak
https://alvareztrujillolab.com/
Biofabrication
List of Monterrey Institute of Technology and Higher Education faculty


"Mario Moisés Álvarez: un alumno becado que hoy diseña y crea biofármacos"



"Mario Moisés Álvarez"
"El ITESM desarrolla vacuna contra la influenza A/H1N1"
"Investigadores vigentes a enero de 2013"
the original
Categories

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.